-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, AC2xwCgL1MNGDfZwHBi9mIXPxsqIeduN9ki5SdtGIszxp54ZA1ZziwVtqj6tPe2D uL6JVLf3C9uA38YxNO0e2A== 0001104659-07-072675.txt : 20071002 0001104659-07-072675.hdr.sgml : 20071002 20071002173104 ACCESSION NUMBER: 0001104659-07-072675 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20071001 FILED AS OF DATE: 20071002 DATE AS OF CHANGE: 20071002 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AMAG PHARMACEUTICALS INC. CENTRAL INDEX KEY: 0000792977 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 042742593 STATE OF INCORPORATION: DE FISCAL YEAR END: 0930 BUSINESS ADDRESS: STREET 1: 125 CAMBRIDGEPARK DRIVE, 6TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02140 BUSINESS PHONE: 6174972070 MAIL ADDRESS: STREET 1: 125 CAMBRIDGEPARK DRIVE, 6TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02140 FORMER COMPANY: FORMER CONFORMED NAME: ADVANCED MAGNETICS INC DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Pereira Brian JG CENTRAL INDEX KEY: 0001298146 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-14732 FILM NUMBER: 071151030 BUSINESS ADDRESS: BUSINESS PHONE: 617-497-2070 MAIL ADDRESS: STREET 1: C/O ADVANCED MAGNETICS, INC. STREET 2: 61 MOONEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02138 4 1 a4.xml 4 X0202 4 2007-10-01 0 0000792977 AMAG PHARMACEUTICALS INC. AMAG 0001298146 Pereira Brian JG C/O AMAG PHARMACEUTICALS, INC. 125 CAMBRIDGEPARK DRIVE, 6TH FLOOR CAMBRIDGE MA 02140 1 1 0 0 President & CEO Common Stock 2007-10-01 4 M 0 10000 9.10 A 31978 D Common Stock 2007-10-01 4 S 0 10000 57.75 D 21978 D Employee Stock Options (Right to Buy) 9.10 2007-10-01 4 M 0 10000 0 D 2015-11-16 Common Stock 10000 128022 D The sales reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person. The shares sold on this date were sold in multiple transactions. This price is the weighted average sales price per share of all shares sold on this date; the actual sale prices per share range from $57.00 to $57.85. 100,000 of these options vested on the date of grant which was November 16, 2005. The remaining 150,000 options vest in three equal annual installments. The first installment became exercisable November 16, 2006. The final two installments become exercisable November 16, 2007 and November 16, 2008. /s/ Joseph L. Farmer, attorney-in-fact 2007-10-02 -----END PRIVACY-ENHANCED MESSAGE-----